'Sinovac Vaccine Probably Won't Arrive Next Month'

"); jQuery("#212 h3").html("

"); jQuery(document).ready(function() { jwplayer.key='EKOtdBrvhiKxeOU807UIF56TaHWapYjKnFiG7ipl3gw='; var playerInstance = jwplayer("jquery_jwplayer_1"); playerInstance.setup({ file: "https://newsstatic.rthk.hk/audios/mfile_1566925_1_20201224181337.mp3", skin: { url: location.href.split('/', 4).join('/') + '/jwplayer/skin/rthk/five.css', name: 'five' }, hlshtml: true, width: "100%", height: 30, wmode: 'transparent', primary: navigator.userAgent.indexOf("Trident")>-1 ? "flash" : "html5", events: { onPlay: function(event) { dcsMultiTrack('DCS.dcsuri', 'https://news.rthk.hk/rthk/en/component/k2/1566925-20201224.mp3', 'WT.ti', ' Audio at newsfeed', 'WT.cg_n', '#rthknews', 'WT.cg_s', 'Multimedia','WT.es','https://news.rthk.hk/rthk/en/component/k2/1566925-20201224.htm', 'DCS.dcsqry', '' ); } } }); }); });
2020-12-24 HKT 11:42
A government adviser on the pandemic said on Thursday that there will likely be a month's delay for Sinovac's vaccine to reach Hong Kong, as reports said the release of the jab's latest trial results in Brazil is being pushed back.
The mainland vaccine manufacturer was originally expected to publish its vaccine's phase three efficacy data around Wednesday, but it has now asked for the release to be put back by up to 15 days so that it can analyse the data from Brazil alongside that collected in Indonesia and Turkey.
Brazilian researchers said on Wednesday that preliminary data suggests Sinovac jabs are "more than 50 percent effective".
Health Secretary Sophia Chan had previously expected Hong Kong to get hold of the vaccine in January and have people injected by February or March.
But Chinese University's Professor David Hui said on a radio programme that the jabs will probably arrive only in February, adding that the BioNTech/Fosun Pharma vaccine may be the first available in the city.
Meanwhile, University of Hong Kong microbiologist Ho Pak-leung played down concerns over Sinovac’s delay in announcing the latest clinical data.
“For mainland vaccines, relevant departments like the National Medical Products Administration have tight supervision over the production and other areas,” he told an RTHK programme.
He added that the technology used by Sinovac to make the vaccine is mature.
But he urged the government to keep pushing for more information on the vaccine's efficacy on mutated coronavirus strains. (Additional reporting by Reuters)
Hong Kong Launches Smart Seniors Anti-Scam Ambassador Programme To Protect The Elderly
The Hong Kong Monetary Authority (HKMA) and the Hong Kong Association of Banks (HKAB) jointly organised the launch cere... Read more
Payment Connect Sees Active Participation In Cross-Boundary Remittances
The People’s Bank of China (PBoC) and the Hong Kong Monetary Authority (HKMA) officially launched Payment Connect on ... Read more
GoTyme Hong Kong Is Entering The Scene With Flexible Financing
GoTyme Hong Kong, which is part of the GoTyme Merchant Cash Advance (MCA) Asia business line under Tyme Group, announce... Read more
BGE Is Hong Kongs Latest Licensed Virtual Asset Trading Platform
Hong Kong BGE Limited (BGE) has secured its license to operate as a virtual asset trading platform (VATP) as of 17 June... Read more
China Backs Digital Yuan And Promotes Multi-Polar Currency System
The head of China’s central bank has promised to boost the global adoption of the digital yuan and called for the dev... Read more
JD Targets Stablecoin Licenses In Multiple Markets For Faster Payments
JD.com plans to secure stablecoin licenses in a series of major markets, founder Richard Liu announced at a Beijing pre... Read more